|
1
|
Garrett WS, Gordon JI and Glimcher LH:
Homeostasis and inflammation in the intestine. Cell. 140:859–870.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Turner JR: Intestinal mucosal barrier
function in health and disease. Nat Rev Immunol. 9:799–809. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mayer EA and Tillisch K: The brain-gut
axis in abdominal pain syndromes. Annu Rev Med. 62:381–396. 2011.
View Article : Google Scholar
|
|
4
|
Clayburgh DR, Shen L and Turner JR: A
porous defense: the leaky epithelial barrier in intestinal disease.
Lab Invest. 84:282–291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Förster C: Tight junctions and the
modulation of barrier function in disease. Histochem Cell Biol.
130:55–70. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harhaj NS and Antonetti DA: Regulation of
tight junctions and loss of barrier function in pathophysiology.
Int J Biochem Cell Biol. 36:1206–1237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tsukita S and Furuse M: The structure and
function of claudins, cell adhesion molecules at tight junctions.
Ann N Y Acad Sci. 915:129–135. 2000. View Article : Google Scholar
|
|
9
|
Groschwitz KR and Hogan SP: Intestinal
barrier function: molecular regulation and disease pathogenesis. J
Allergy Clin Immunol. 124:3–20; quiz 21–22. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van Itallie CM and Anderson JM: Claudins
and epithelial para-cellular transport. Annu Rev Physiol.
68:403–429. 2006. View Article : Google Scholar
|
|
11
|
Schneeberger EE and Lynch RD: The tight
junction: a multifunctional complex. Am J Physiol Cell Physiol.
286:C1213–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Turksen K and Troy TC: Barriers built on
claudins. J Cell Sci. 117:2435–2447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saitou M, Furuse M, Sasaki H, Schulzke JD,
Fromm M, Takano H, Noda T and Tsukita S: Complex phenotype of mice
lacking occludin, a component of tight junction strands. Mol Biol
Cell. 11:4131–4142. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dang J, Ardila-Hani A, Amichai MM, Chua K
and Pimentel M: Systematic review of diagnostic criteria for IBS
demonstrates poor validity and utilization of Rome III.
Neurogastroenterol Motil. 24:853–e397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gitter AH, Bendfeldt K, Schulzke JD and
Fromm M: Leaks in the epithelial barrier caused by spontaneous and
TNF-alpha-induced single-cell apoptosis. FASEB J. 14:1749–1753.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeissig S, Burgel N, Günzel D, et al:
Changes in expression and distribution of claudin 2, 5 and 8 lead
to discontinuous tight junctions and barrier dysfunction in active
Crohn's disease. Gut. 56:61–72. 2007. View Article : Google Scholar
|
|
17
|
Yuan B, Zhou S, Lu Y, Liu J, Jin X, Wan H
and Wang F: Changes in the expression and distribution of claudins,
increased epithelial apoptosis, and a mannan-binding
lectin-associated immune response lead to barrier dysfunction in
dextran sodium sulfate-induced rat colitis. Gut Liver. Feb
26–2015.Epub ahead of print. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kyoko OO, Kono H, Ishimaru K, Miyake K,
Kubota T, Ogawa H, Okumura K, Shibata S and Nakao A: Expressions of
tight junction proteins Occludin and Claudin-1 are under the
circadian control in the mouse large intestine: Implications in
intestinal permeability and susceptibility to colitis. PLoS One.
9:e980162014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barbara G, Zecchi L, Barbaro R, et al:
Mucosal permeability and immune activation as potential therapeutic
targets of probiotics in irritable bowel syndrome. J Clin
Gastroenterol. 46(Suppl): S52–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barbara G: Mucosal barrier defects in
irritable bowel syndrome. Who left the door open? Am J
Gastroenterol. 101:1295–1298. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Santos J, Guilarte M, Alonso C and
Malagelada JR: Pathogenesis of irritable bowel syndrome: the mast
cell connection. Scand J Gastroenterol. 40:129–140. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guilarte M, Santos J, de Torres I, et al:
Diarrhoea-predominant IBS patients show mast cell activation and
hyperplasia in the jejunum. Gut. 56:203–209. 2007. View Article : Google Scholar
|
|
23
|
Cenac N, Andrews CN, Holzhausen M, et al:
Role for protease activity in visceral pain in irritable bowel
syndrome. J Clin Invest. 117:636–647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barbara G, Wang B, Stanghellini V, et al:
Mast cell-dependent excitation of visceral-nociceptive sensory
neurons in irritable bowel syndrome. Gastroenterology. 132:26–37.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Iweala OI and Nagler CR: Immune privilege
in the gut: the establishment and maintenance of non-responsiveness
to dietary antigens and commensal flora. Immunol Rev. 213:82–100.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wisner DM, Harris LR III, Green CL and
Poritz LS: Opposing regulation of the tight junction protein
claudin-2 by interferon-gamma and interleukin-4. J Surg Res.
144:1–7. 2008. View Article : Google Scholar
|
|
27
|
Jacob C, Yang PC, Darmoul D, et al: Mast
cell tryptase controls paracellular permeability of the intestine.
Role of protease-activated receptor 2 and beta-arrestins. J Biol
Chem. 280:31936–31948. 2005. View Article : Google Scholar : PubMed/NCBI
|
